XNCR Q3 2017 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$861M

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M-9.3% YoY

Gross Profit

-$12M-173.7% margin

Operating Income

-$16M-232.6% margin

Net Income

-$16M-219.5% margin

EPS (Diluted)

$-0.33

QoQ Revenue Growth

-46.9%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$7M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$398M

Total Liabilities

$108M

Stockholders' Equity

$291M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$8M	-9.3%
Gross Profit	-$12M	-$6M	-97.2%
Operating Income	-$16M	-$9M	-78.2%
Net Income	-$16M	-$8M	-92.7%